TheraSphere With Durvalumab and Tremelimumab for HCC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Aiwu Ruth He, MD PhD
Georgetown University
Principal Investigator - Beau Toskich, MD
Mayo Clinic
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
36 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chu Nantes
Rennes, Cedex, France
- Hôpital Beaujon
Clichy, Hauts De Seine, France
- Chu Grenoble
Grenoble, Isere, France
- Chu de Bordeaux - Hôpital Haut-Lévêque
Clermont-Ferrand, France
- Chu Henri Mondor
Créteil, France
- Chru de Lille
Lille, France
- Chu Montpellier
Montpellier, France
- Chu Angers - Hôpital Hôtel Dieu
Nantes, France
- Crlcc Eugene Marquis
Rennes, France
- Hopital Paul Brousse
Villejuif, France
- National Cancer Institute of Milan, Italy
Milan, Italy
- Irccs - Regina Elena Cancer Institute
Roma, Italy
- Azienda Sanitaria Universitaria Integrata Friuli Centrale (asu Fc)
Udine, Italy
- Hospital Clinic de Barcelona
Barcelona, Catalonia, Spain
- Clinica Universidad de Navarra
Pamplona, Navarre, Spain
- Hospital Universitario Central de Asturias
Oviedo, Principality of Asturias, Spain
- Hospital Gregorio Maranon
Madrid, Spain
- Hospital Universitario Virgen de Las Nieves
Madrid, Spain
- Hospital. Ramon Y Cajal
Madrid, Spain
- Hospital Universitari
Valencia, Spain
- Clinico de Valladolid
Valladolid, Spain
- University Hospital of Bern
Bern, Switzerland
- University Hospital Geneva (hug)
Geneva, Switzerland
- University of Arizona- Banner Health
Tucson, Arizona, United States
- University of California San Diego
San Diego, California, United States
- University of California San Francisco
San Francisco, California, United States
- Georgetown University
Washington D.C., District of Columbia, United States
- Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
- Mayo Clinic
Jacksonville, Florida, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Chicago Hospital
Chicago, Illinois, United States
- Ochsner Clinic Foundation
New Orleans, Louisiana, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Washington University (barnes-Jewish Hospital)
St Louis, Missouri, United States
- Columbia University Irving Medical Center
New York, New York, United States
- Intermountain Health
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Nov 2023
- Primary completion
- 30 Jun 2027
- Completion
- 30 Jun 2027
- Last update posted
- 23 Jun 2026
- Registered enrollment
- 100
- Registry id
- NCT05063565
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.